Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of September 22nd, we are planning to work on 25 projects, including:

Reimbursement

1. Delivering reimbursement analysis for minimally invasive cardiovascular technology in 13 European countries
2. Delivering reimbursement analysis for diagnostic procedures in the pulmonary disease area in Poland and Sweden
3. Delivering reimbursement analysis for a minimally invasive intervention in the gastrointestinal area in France and Germany
4. Working on market access strategy for the administration of a medication in outpatient settings in England, France, Germany, and Sweden
5. Working on reimbursement analysis for molecular diagnostic technologies in 12 European countries
6. Working on market size analysis for neurovascular technologies in eight European countries
7. Working on market size analysis for cardiac, gastrointestinal, and peripheral vascular procedures in Finland, Norway, and Sweden
8. Working on reimbursement analysis for cardiovascular support technologies in England and France
9. Working on reimbursement analysis for medical aids used in the urology area in France, Germany, and Italy
10. Working on reimbursement analysis for medical aids used in the gastrointestinal area in France, Germany, and Italy
11. Working on reimbursement analysis for cardiac devices in 10 European countries
12. Working on reimbursement analysis for a minimally invasive orthopedic procedure in France
13. Working on reimbursement analysis for an implantable device in the urology area in England, France, Germany, and Spain
14. Working on reimbursement analysis for a medical device used in gastrointestinal surgery in Belgium, England, France, and Italy 
15. Working on reimbursement analysis for a diagnostic test for infectious diseases in England, France, Germany, Italy, and Spain
16. Working on reimbursement analysis for diagnostic imaging procedures in the cardiovascular area in 11 European countries
17. Initiating work on reimbursement analysis for home-based in-vitro diagnostic tests in nine European countries 

HEOR

1. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
2. Working on a systematic review and meta-analysis for an in vitro diagnostic test
3. Working on a clinical value dossier for an in vitro diagnostic test in the neurology area 
4. Working on a systematic literature review update for a minimally invasive technology in the neurology area
5. Working on evidence gap analysis for medical aids used in the urology area in France and Germany
6. Working on evidence gap analysis for medical aids used in the gastrointestinal area in France and Germany
7. Working on evidence gap analysis for a minimally invasive orthopedic procedure in France 
8. Working on a systematic literature review on point-of-care diagnostic tests in the pulmonary area

Let us know if you need any market access or HEOR support for your medical technology in Europe.